Purchases and Sales Made in Q2 2024 in Silence Therapeutics PLC (SLN)
This table provides information about the institutional ownership of Silence Therapeutics PLC (SLN) during Q2 2024. The information is specifically focused on institutions that hold shares of Silence Therapeutics plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Aquilo Capital Management, LLC
San Francisco, CA |
SELL
|
- |
-74K- 12.89% |
$1.35M - $1.77M
|
500K
$3.11M
|
|
|
Aug 13, 2024
Q2 2024
|
M28 Capital Management LP
Stamford, CT |
SELL
|
- |
-114K- 38.18% |
$2.09M - $2.73M
|
185K
$1.15M
|
|
|
Aug 14, 2024
Q2 2024
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-139K- 44.13% |
$2.55M - $3.32M
|
176K
$1.09M
|
|
|
Aug 14, 2024
Q2 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-148K- 61.88% |
$2.7M - $3.53M
|
90.9K
$565K
|
|
|
Aug 14, 2024
Q2 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-284K- 17.28% |
$5.2M - $6.79M
|
1.36M
$8.46M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.36M- 81.72% |
$24.9M - $32.5M
|
304K
$1.89M
|